Adamis Pharmaceuticals Corp·4

Feb 1, 7:11 PM ET

DENBY WILLIAM C 4

4 · Adamis Pharmaceuticals Corp · Filed Feb 1, 2019

Insider Transaction Report

Form 4
Period: 2019-01-30
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-01-30+30,00030,000 total
    Exercise: $3.09Exp: 2029-01-30Common Stock (30,000 underlying)
Footnotes (1)
  • [F1]The option vests monthly over a period of twelve months commencing on the grant date. The option is granted pursuant to the 2009 Equity Incentive Plan and is subject to other provisions as are set forth in the option agreement relating to such grant under the plan.

Documents

1 file
  • 4
    primary_01.xmlPrimary

    PRIMARY DOCUMENT